Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11579112 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
Conditions: Non-Hodgkin's Lymphoma;   Follicular Lymphoma
Interventions: Drug: Iodine I -01 Tositumomab (Bexxar);   Procedure: External Beam Radiation Therapy
2 Completed
Has Results
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab

Indicates status has not been verified in more than two years